Update: Nevirapine-based fixed-dose combination ARVs

24 April 2003

This article originally appeared in HIV & AIDS treatment in practice, an email newsletter for healthcare workers and community-based organisations in resource-limited settings published by NAM between 2003 and 2014.

This article is more than 23 years old.

Editors’ picks from other sources

Sexually transmitted infections prevention

WHO issues first recommendation on doxycycline post-exposure prophylaxis to help prevent sexually transmitted infections

The World Health Organization (WHO) has issued its first recommendation on the use of doxycycline post-exposure prophylaxis (PEP) – commonly referred to as doxyPEP – for the prevention of bacterial sexually transmitted infections (STIs) among men who have sex with men and transgender women.

World Health Organization

19 May 26

Update: Nevirapine-based fixed-dose combination ARVs

Update: Nevirapine-based fixed-dose combination ARVs

Greater risk of schizophrenia among people with HIV – especially those who inject drugs

Syphilis cases increasing in women in the UK

UK sexual health conference debates move to less frequent STI screening

People living with HIV join outreach teams as re-engagement in care moves up the political agenda

Toronto man cured of HIV after stem cell transplant

My diagnosis seemed like a death sentence – how have I survived for another 40 years?

WHO issues first recommendation on doxycycline post-exposure prophylaxis to help prevent sexually transmitted infections

HIV goals for 2030: England on-target for HIV-related mortality but not for diagnoses

Modelling study predicts PrEP efficacy driven by drug levels in cells: results in men match those previously reported in women

Sharing is caring: HIV prevention pills are being shared in PrEP ‘Stokvels'